Should Covid-19 vaccine manufacturers' IP rights be waived?
As Covid-19 vaccines are rolling out in wealthy countries but poorer ones struggle to get supplies, a debate over the rights of drug companies to guard their intellectual property is intensifying. The latest battleground was a council meeting at the World Trade Organization last week, where countries staked out their positions on whether rules needed to be suspended to get more doses made. The issue at stake is how to vaccinate billions of...
United States United Kingdom South Africa United Arab Emirates Tedros Adhanom Ghebreyesus Shahar Hameiri
Source: msn.com